We’re finally starting to see experiments that don’t just chase validation — they redefine how evidence itself gets created.
We’re finally starting to see experiments that don’t just chase validation — they redefine how evidence itself gets created.
I can’t help but wonder:
I can’t help but wonder:
And yet, ten years later, those same “reckless” models became the new normal — for better, for worse, but undeniably permanent.
And yet, ten years later, those same “reckless” models became the new normal — for better, for worse, but undeniably permanent.
Blogger made anyone a journalist.
E*Trade let anyone trade stocks without a broker.
YouTube turned anyone with a camera into a potential media brand.
Uber and Lyft made anyone a taxi driver.
Blogger made anyone a journalist.
E*Trade let anyone trade stocks without a broker.
YouTube turned anyone with a camera into a potential media brand.
Uber and Lyft made anyone a taxi driver.
But could this finally be healthcare’s democratization moment?
But could this finally be healthcare’s democratization moment?
There's so much risk in the pharma compounds, trial managers try to derisk everything else. So “innovation” usually happens only around the edges.
There's so much risk in the pharma compounds, trial managers try to derisk everything else. So “innovation” usually happens only around the edges.
I built a company that ran studies with pharma sponsors in the U.S. and EU — and it did fine.
But I realized something uncomfortable: the system isn’t designed to evolve.
I built a company that ran studies with pharma sponsors in the U.S. and EU — and it did fine.
But I realized something uncomfortable: the system isn’t designed to evolve.